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Abstract 
Paracetamol is an effective analgesic but its mechanism of action is unclear.  We 
investigated the effect of paracetamol and the analgesic adjuvant caffeine on the activity 
of NO synthase in mouse spinal cord and cerebellar slices in vitro, by measuring the 
conversion of [3H]arginine to [3H]citrulline.  Paracetamol (100 µM) had no effect on NO 
synthase activity in cerebellum, but in the spinal cord both paracetamol (100 µM) and 
caffeine (30 µM) attenuated glutamate (5 mM)-induced [3H]citrulline production and in 
combination they abolished it.  In conclusion paracetamol inhibits spinal cord NO 
synthesis and this may be related to its analgesic effects. 
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1. Introduction 
Paracetamol has been used as an over-the-counter analgesic for several years, although its 
mechanism of action is still not completely understood (Prescott, 2001; Simmons et al., 
2004; Kis et al., 2005).  It has been suggested (Bjorkman, 1994) that inhibition of nitric 
oxide (NO) release is involved in the antinociceptive effect of paracetamol.  NO has been 
suggested to have various roles in the mediation of pain, and inhibition of its formation 
can have different effects dependent on the pain stimulus.  Inhibition of NO synthesis has 
an antinociceptive effect when pain stems from a chemical or thermal insult.  For 
example administration of the NO synthase (NOS) inhibitor NG-nitro-L-arginine methyl 
ester (L-NAME) blocks thermal hyperalgesia and the nociceptive response to formalin in 
rats and mice, and this effect is reversed by the administration of the NO precursor L-
arginine (Kitto et al., 1992; Malmberg and Yaksh, 1993; Yamamoto and Shimoyama, 
1995; Sakurada et al., 2001).  Nociception induced by acetic acid in the writhing test in 
mice, has also been found to be inhibited by L-NAME (Duarte and Ferreira, 2000).  In 
addition, both formalin injection and administration of the glutamate receptor agonist N-
methyl-D-aspartate (NMDA) have been shown to increase the release of NO metabolites 
in the periphery, and this release was suppressed by the administration of the NO 
synthase inhibitor NG-monomethyl-L-arginine or the NMDA receptor antagonist D,L-2-
amino-5-phosphonovaleric acid (Omote et al., 2000).  It has therefore been suggested that 
the NO contributes to hyperalgesia by activating the spinal NO/cyclic GMP pathway and 
that this release of NO is mediated via the activation of the NMDA receptor in the 
periphery (Omote et al., 2000). 
The non-selective inhibitor LG-nitro-L-arginine and the nNOS selective inhibitor 7-
nitroindazole administered intraperitoneally both potentiated the antinociceptive action of 
paracetamol in rats subjected to the paw pressure, whereas the iNOS inhibitor L-N6 (1-
iminoethyl)lysine had no effect (Bujalska and Gumulka, 2001).  Central administration of 
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L-NAME also potentiated the antinociceptive effect of paracetamol and it was concluded 
that nNOS may be involved in both the peripheral and the central action of paracetamol 
(Bujalska, 2003).  The inhibition by paracetamol of NMDA or substance P-induced 
hyperalgesia was attenuated by the administration of the NO synthase substrate L-
arginine, indicating that paracetamol may inhibit the NMDA-NO pathway (Bjorkman, 
1994). 
These findings suggest that the analgesic action of paracetamol could be partially 
mediated through the inhibition of NO synthesis in the spinal cord.  The aim of this study 
was therefore to determine directly whether paracetamol inhibited NOS in the spinal 
cord. We have shown antinociceptive effects of paracetamol in both spinal and 
supraspinal pain tests in the mouse (Godfrey et al., 2006) and also binding of 
[3H]paracetamol to mouse spinal cord (Godfrey et al., 2005), so we chose the mouse as 
our experimental model for these studies.  We also looked at the effect on NO synthesis 
of caffeine alone and in combination with paracetamol, because of the widespread use of 
paracetamol/caffeine combinations as over-the-counter analgesics. 
2. Materials and Methods 
CD1 male mice (10 day old, 6 per experiment) were killed by decapitation and the brains 
and spinal cords rapidly removed.  Adult mice were not used in these studies because in 
pilot experiments we were unable to detect NOS activity in response to drug treatment. 
The cerebella and spinal cord were dissected free, washed in magnesium-free, ice-cold 
Krebs buffer (composition (mM) NaCl, 118; KCl, 4.7; KH2PO4, 1.2; NaHCO3, 25.0; 
glucose, 11.0 and CaCl2, 2.0, continuously gassed with 95% O2/5% CO2) and 
immediately cross-chopped (0.4 mm × 0.4 mm) on a McIlwain tissue chopper.  Tissue 
slices were suspended in 250 ml buffer, and incubated at 37 °C for 15 min.   The buffer 
was then decanted off and replaced with fresh buffer and incubated at 37 °C for a further 
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60 min to allow the slices to equilibrate.  The slices were then allowed to settle under 
gravity, the buffer decanted off and fresh buffer added.  This washing step was carried 
out twice.  The slices were then allowed to settle and 50 µl of packed slices were 
transferred to 5 ml polypropylene tubes containing 200µl Krebs buffer and 30 µl buffer 
(drug vehicle) or test substance (final concentrations: 100 µM L-NAME, 100 µM 
paracetamol, 30 µM caffeine or 100 µM paracetamol + 30 µM caffeine, total vol. 280 µl).  
Tubes were gassed, capped and incubated at 37 °C for 15 min. Glutamate (5 mM) plus 
glycine (10 µM) or an equal vol. of buffer were then added to the relevant tubes prior to 
the addition of [3H]L-arginine (3 µCi/ml, 20µl) giving a final vol. of 330 µl.  The tubes 
were then gassed and capped and incubated at 37 °C for a further 15 min. 
The assay was terminated by the addition of 750 µl ice-cold Krebs buffer containing 4 
mM EDTA/5 mM L-arginine, and then centrifuged (4,000 × g at 4 °C for 5 min). The 
pellet was then resuspended in 1 ml of ice-cold 1M trichloroacetic acid, the samples were 
centrifuged (4,000 × g at 4 °C for 5 min) and the supernatant was removed.  
Trichloroacetic acid was extracted three times with 2 ml of water-saturated diethyl ether 
and then neutralised with 2 ml of 20 mM HEPES buffer (pH 6.0).  The neutralized 
samples were applied to 2 ml columns of Dowex AG50WX-8 (Na+ form), eluted with 2 
ml of distilled water and [3H]citrulline in the eluate was quantified by liquid scintillation 
spectroscopy. 
Results were expressed as disintegrations per minute  (dpm) of [3H]citrulline (mean ± 
S.E.M). Statistical analysis was performed by one-way ANOVA (for the factor 
treatment), followed by Scheffe’s post hoc test. 
 [3H]Arginine (40 Ci/mmol) was purchased from Tocris Cookson Ltd (Bristol, UK). 
Dowex AG50WX-8 and HEPES were supplied by Biorad Laboratories Ltd 
(Hertfordshire, UK) and Calbiochem Merck Biosciences (Nottingham, UK) respectively. 
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L-arginine, EDTA, L-NAME, L-glutamate, paracetamol and caffeine were obtained from 
Sigma Aldrich (Dorset, UK).  NaOH, glucose, and glycine were obtained from VWR 
International (Lutterworth, UK). All other chemicals were purchased from Fisher 
Scientific (Loughborough, UK). All drugs were made up in magnesium-free Krebs 
bicarbonate buffer.   
 
3. Results 
3.1 NO synthase activity in cerebellar slices 
The basal production of [3H]citrulline in cerebella from 10 day old mice was 2768 ± 110 
dpm (n=5).  Glutamate (5 mM) plus glycine (10 µM) significantly increased the 
production of [3H]citrulline, which was abolished by preincubation with L-NAME (100 
µM).  L-NAME (100 µM) alone did not alter the basal production of [3H]citrulline.  
Paracetamol (100 µM) did not alter the basal production of [3H]citrulline and had no 
effect on the glutamate/glycine-induced increase (Fig 1A).  
3.2 NO synthase activity in spinal cord slices 
The basal production of [3H]citrulline in spinal cord slices from 10 day old mice was 625 
± 107 dpm (n=7).   L-NAME (100 µM), paracetamol (100 µM) and caffeine (30 µM) 
alone or in combination did not alter the basal production of [3H]citrulline.  Glutamate (5 
mM) plus glycine (10 µM) produced a significant increase in production of [3H]citrulline, 
which was significantly attenuated by preincubation with L-NAME (100 µM).    In the 
presence of either paracetamol (100 µM) or caffeine (30 µM) there was no significant 
stimulation of [3H]citrulline production by glutamate (5 mM) plus glycine (10 µM), 
showing an attenuation by these drugs of glutamate/glycine-induced NO synthesis.  There 
was a further reduction in [3H]citrulline production when the drugs were added together, 
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and a significant difference between glutamate plus glycine alone and glutamate plus 
glycine in the presence of a combination of paracetamol (100 µM) and caffeine (30 µM) 
(Fig 1B). 
4. Discussion 
The mechanism of NO synthesis and its inhibition has previously been studied in the 
cerebellum of 10 day old rat pups (Bredt and Snyder, 1989; Garthwaite et al., 1989; Toms 
and Roberts, 1994) as high levels of nNOS are observed in this tissue at this age.  NOS 
activity in the cord has not been previously measured using the stoichiometric conversion 
of [3H]arginine to [3H]citrulline, so the cerebellum was also used as a brain model of 
NOS activity to validate the method.  The concentration of paracetamol (100 µM) was 
chosen to reflect peak plasma concentrations following administration of 10-20 mg/kg 
paracetamol in vivo, equivalent to a dose of less that 1 g of paracetamol in man and 
therefore within the therapeutic range (Prescott, 2001).  The concentration of caffeine (30 
µM) was chosen to be within the range selective for adenosine receptor blockade and 
equivalent to a dose of around 7 mg/kg, a dose at the high end of those which could be 
achieved in man (Fredholm et al., 1996).  In each case these doses are similar to those 
that we have previously used in in vivo studies in mice (10-200 mg/kg paracetamol, 10 
mg/kg caffeine (Godfrey et al., 2006).  While previous studies have reported that caffeine 
enhances the antinociceptive effect of paracetamol in mice, rats and humans (Laska et al., 
1983; Granados-Soto et al., 1993; Engelhardt et al., 1997), we found instead that caffeine 
can inhibit the antinociceptive effects of paracetamol in mice (Godfrey et al., 2006).  This 
discrepancy may reflect the fact that caffeine is a non-selective adenosine receptor 
antagonist and that blockade of adenosine A1 and A2A receptors may have opposing 
effects on pain pathways.   
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In agreement with Bredt & Snyder (1989), glutamate (5 mM) plus glycine (10 µM) 
produced a robust increase (85 % increase relative to control) in NOS activity in 
cerebellar slices from 10 day old mice.  Preincubation with L-NAME (100 µM) 
completely abolished the glutamate/glycine-induced stimulation showing that this method 
was sensitive enough to detect a possible reduction in NO production by paracetamol.  
However, paracetamol failed to influence significantly either basal or glutamate/glycine-
induced NOS activity in neonatal mouse cerebellar slices.  This is in agreement with a 
brief report by Raffa (2002) who found no evidence that paracetamol (0.01-10 mM) 
directly inhibited nNOS in the rat cerebellum.  
Basal production of NO was significantly stimulated (185 % increase relative to control) 
in the presence of glutamate (5 mM)/glycine (10 µM) in spinal cord slices from 10 day 
old mice.  This stimulation was also significantly attenuated by L-NAME as in the 
cerebellum.  In contrast to the cerebellum, paracetamol (100 µM) attenuated the 
glutamate/glycine-induced synthesis of NO, but had no effect on the basal release of NO.  
The reason for the different effect of paracetamol on NO production in the two sites is 
unclear.  Caffeine (30 µM) also had no effect on basal production but attenuated the 
glutamate/glycine-induced stimulation.  In the rat hippocampus adenosine A1 receptor 
stimulation has been shown to inhibit both basal and NMDA-induced synthesis of NO, 
(Bhardwaj et al., 1995), so adenosine A1 receptor antagonism might be expected to 
potentiate NO synthesis.  However, in our experiments caffeine attenuated NO 
production, suggesting instead an action via adenosine A2 receptor antagonism. 
When paracetamol (100 µM) and caffeine (30 µM) together were preincubated with 
spinal cord slices they significantly inhibited the glutamate/glycine-induced stimulation 
to a greater extent than the paracetamol or caffeine alone.  This enhancement by caffeine 
of the effects of paracetamol is similar to the reported enhancement by caffeine of the 
analgesic effects of paracetamol (Laska et al., 1983; Granados-Soto et al., 1993; 
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Engelhardt et al., 1997), although from the results presented here it cannot be concluded 
that the inhibition of NO synthesis is responsible for these analgesic effects.  However, 
our direct demonstration of the inhibition of spinal cord NO synthesis by paracetamol 
supports the suggestion made by Bjorkman (1994) on the basis of behavioural studies 
that the analgesic effect of paracetamol is partly through the spinal inhibition of 
hyperalgesia-induced NO release.   
In conclusion, in the mouse cerebellum and spinal cord glutamate/glycine induced the 
generation of NO.  Paracetamol and caffeine either alone or in combination did not affect 
the basal synthesis of NO but attenuated glutamate/glycine-induced NO synthesis in the 
spinal cord but not the cerebellum.  It is also apparent that caffeine enhanced the 
inhibitory effect of paracetamol on NO production in the spinal cord.  
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Figure 1.  The effects of paracetamol (100 µM), caffeine (30 µM) or L-NAME (100 µM) 
on glutamate-induced [3H]citrulline production as a measure of NO synthase activity in 
A) cerebellum slices (n= 6) and B) spinal cord slices (n= 3-7) of 10 day old mice.  
Results on the left hand sides of the figures show [3H]citrulline production in the 
presence of glutamate (5mM) plus glycine (10 µM), while results on the right hand sides 
show [3H]citrulline production in the presence of vehicle alone.  Dotted lines show the 
basal production of [3H]citrulline in the absence of any drugs.  Data are the means ± 
S.E.M. * Basal vs treatment; # Treatment vs glutamate plus glycine (P< 0.05, ANOVA, 
Scheffe’s post hoc test). 
 
